Prognose

Für dieses Unternehmen liegen uns keine Analysten-Daten vor.

Scoring-Modelle

Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.

Itamar Medical Ltd. Sponsored ADR (ITMR) Reports Q3 Loss, Lags Revenue Estimates
Itamar Medical Ltd. Sponsored ADR (ITMR) delivered earnings and revenue surprises of -63.33% and 0.98%, respectively, for the quarter ended September 2021.» Mehr auf zacks.com
Analysts Estimate Itamar Medical Ltd. Sponsored ADR (ITMR) to Report a Decline in Earnings: What to Look Out for
Itamar Medical Ltd. Sponsored ADR (ITMR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.» Mehr auf zacks.com
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Merger of Itamar Medical Ltd. with ZOLL Medical Corporation
New York, New York--(Newsfile Corp. - September 13, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All Persons or Entities who purchased Itamar Medical Ltd. (NASDAQ: ITMR) ("Itamar" of the "Company") stock prior to September 13, 2021.You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the merger of Itamar with ZOLL Medical Corporation. ("ZOLL Medical"). Under t» Mehr auf newsfilecorp.com

Im letzten Jahr hatte Itamar Medical einen Umsatz von 33,69 Mio€ und ein Nettoeinkommen von −8,98 Mio€